Combined treatment with LGG and PD-1 inhibitors shifted the gut microbial community towards enrichment in Lactobacillus murinus and Bacteroides uniformis, known to increase DC activation and CD8+ tumor recruitment and was consistent with the better prognosis of the combined therapy. This evidence concerns the gene CD8A and neoplasm.